HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review.

Abstract
Vancomycin-resistant enterococci (VRE) are a rare cause of meningitis, occurring primarily in patients who have undergone neurosurgical procedures. We describe the first reported case of VRE meningitis successfully treated with linezolid. A 56-y-old female with subarachnoid hemorrhage underwent ventriculostomy and embolization of cerebral aneurysms. Her postoperative course was complicated by multiple infections needing repeated antibiotic courses, culminating in the development of VRE meningitis. She was treated with 600 mg of i.v. linezolid (MIC < 0.75 microg/ml) every 12 h for 6 weeks. After the fourth dose, peak and trough linezolid concentrations were 11.45 and 0.14 microg/ml in serum and 3.19 and 2.39 microg/ml in cerebral spinal fluid (CSF). On Day 19 of linezolid therapy, serum and CSF trough concentrations were 1.53 and 2.98 microg/ml, respectively. Linezolid achieved sufficient CSF concentrations to bring about clinical and bacteriological cure. We conclude that i.v. linezolid may be a useful option for treating VRE meningitis. We also present findings of a literature review, which identified 11 cases of VRE meningitis treated with other pharmacologic agents with mixed success.
AuthorsZ H Shaikh, C A Peloquin, C D Ericsson
JournalScandinavian journal of infectious diseases (Scand J Infect Dis) Vol. 33 Issue 5 Pg. 375-9 ( 2001) ISSN: 0036-5548 [Print] England
PMID11440224 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Acetamides
  • Anti-Bacterial Agents
  • Oxazolidinones
  • Linezolid
Topics
  • Acetamides (therapeutic use)
  • Anti-Bacterial Agents (therapeutic use)
  • Enterococcus faecium (drug effects)
  • Female
  • Gram-Positive Bacterial Infections (drug therapy, microbiology)
  • Humans
  • Linezolid
  • Male
  • Meningitis, Bacterial (drug therapy, microbiology)
  • Middle Aged
  • Oxazolidinones (therapeutic use)
  • Treatment Outcome
  • Vancomycin Resistance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: